Insight Advisors’s Cardinal Health CAH Stock Holding History

Insight Advisors’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,078	Closed	-$230K	–	294
2024 Q3	$230K	Hold	2,078	–	–	0.04%	269
2024 Q2	$204K	Hold	2,078	–	–	0.04%	278
2024 Q1	$233K	Buy	+2,078	New	+$224K	0.04%	267

Other funds holding CAH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Insight Advisors's CAH Position: Q4 2024 in Review

Insight Advisors sold out of Cardinal Health (CAH) in Q4 2024, closing a stake of 2,078 shares — an estimated $230K sold.

Insight Advisors first reported a position in CAH in Q1 2024 and held it in 3 quarters. The position peaked at $233K in Q1 2024. 1,097 funds tracked by Wall St. Rank hold CAH as of Q4 2024.

Insight Advisors reported no remaining Cardinal Health position as of Q4 2024 after selling out during the quarter.
Insight Advisors sold 2,078 Cardinal Health shares in Q4 2024, an estimated $230K.
Insight Advisors first reported a position in Cardinal Health in Q1 2024 and held it in 3 quarters.
Insight Advisors's Cardinal Health position peaked at $233K in Q1 2024.
1,097 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2024.

Based on Insight Advisors's 13F filing for Q4 2024, filed 27 Jan 2025.